Loading…
Disclosed for 84 months, Sep 2012 to Aug 2019. This scheme is no longer reporting.Published as: RELIANCE GROWTH FUND (Mid Cap Fund- An open ended equity scheme predominantly investing in mid cap stocks)
Reliance Growth Fund is an active equity fund in the Mid Cap category from Nippon India Mutual Fund. In September 2012 it disclosed 57 stocks worth ₹5,698 Cr. Its largest positions were Strides Pharma Science Limited (5.4%), ICICI Bank Limited (5.1%), Divi's Laboratories Limited (4.5%); the ten largest together made up 40.8% of the portfolio, and Banks was the biggest sector at 12.0% of its equity. Cash and debt stood at 2.9%.
Top-10 weight is higher than 85% of peers
Holds more stocks than 27% of peers
Holds more cash than 58% of peers
What these mean: concentration · cash
Every line the fund disclosed, with the change against the previous month. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
This is the earliest month on record for the fund.
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
No earlier month with a sector split to compare against.
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Not enough months to draw.
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.
| 77 |
| 2 |
| 7 |
| 3.7% |
| 6.1% |
| — |
| Apr 2019 | ₹6,662 Cr | 82 | 5 | 2 | 1.4% | 4.0% | — |
| Mar 2019 | ₹6,745 Cr | 79 | 3 | 9 | 1.5% | 3.0% | — |
| Feb 2019 | ₹6,361 Cr | 85 | 3 | 5 | 0.9% | 2.5% | — |
| Jan 2019 | ₹6,412 Cr | 87 | 5 | 2 | 2.6% | 3.0% | — |
| Dec 2018 | ₹6,606 Cr | 84 | 3 | 3 | 1.5% | 1.9% | — |
| Nov 2018 | ₹6,486 Cr | 84 | 7 | 7 | 1.4% | 1.8% | — |
| Oct 2018 | ₹6,234 Cr | 84 | 13 | 7 | 3.0% | 3.6% | — |
| Sep 2018 | ₹6,228 Cr | 78 | 5 | 8 | 2.9% | 3.5% | — |
| Aug 2018 | ₹7,027 Cr | 81 | 9 | 5 | 0.9% | 1.3% | — |
| Jul 2018 | ₹6,830 Cr | 77 | 3 | 6 | 2.1% | 2.9% | — |
| Jun 2018 | ₹6,550 Cr | 80 | 4 | 2 | 2.7% | 3.1% | — |
| May 2018 | ₹6,873 Cr | 78 | 9 | 11 | 2.5% | 3.5% | — |
| Apr 2018 | ₹7,177 Cr | 80 | 6 | 6 | 1.3% | 3.1% | — |
| Mar 2018 | ₹6,663 Cr | 80 | 5 | 6 | 1.5% | 5.2% | — |
| Feb 2018 | ₹7,033 Cr | 81 | 5 | 4 | 5.2% | 6.3% | — |
| Jan 2018 | ₹7,266 Cr | 80 | 11 | 11 | 3.3% | 4.7% | — |
| Dec 2017 | ₹7,437 Cr | 80 | 4 | 5 | 1.1% | 2.3% | — |
| Nov 2017 | ₹7,170 Cr | 81 | 5 | 7 | 1.7% | 3.7% | — |
| Oct 2017 | ₹7,103 Cr | 83 | 19 | 7 | 0.8% | 3.1% | — |
| Sep 2017 | ₹6,564 Cr | 71 | 21 | 5 | 4.3% | 6.6% | — |
For any of the 60 earlier months, choose it in “Portfolio as of” at the top of the page.